Health & Wealth
A - Z of Health
Research
Therapy Overviews
Health Guider
Health Insurance
Case Studies
Contributors
Support Groups
Professional Bodies
Resources

Wealth Dynamics Profile Test
metallic taste
 
 


Members Area   :   Update your details   |   Lost password   |   Discussion groups
Practitioner Search Health Centre Search Advertise With Us Join Our Directories

PAEDIATRICS

ZINC SUPPLEMENTATION DECREASES CHILDHOOD INFECTIONS

Researchers in the US analysed ten trials from nine developing countries which assessed the effects of oral zinc in apparently healthy children under 5 years of age. In the continuous trials, pooled odds ratios for diarrhoeal incidence and prevalence were 0.82 and 0.75 respectively, in the zinc-supplemented group compared with controls. Children who took zinc supplements also had an odds ratio of 0.59 for pneumonia. Although the findings highlight the role of zinc supplementation in the management of common infectious diseases in developing countries, copper depletion and interactions with other micronutrients have not been adequately studied. Also, zinc may be seen as another magic bullet like vitamin A, leading to commercial exploitation, which south Asian economies cannot afford.
Ahmad, K
LANCET 1999, 354 (9195) 2057

LACTOBACILLUS GG IN THE PREVENTION OF ANTIBIOTIC-ASSOCIATED DIARRHOEA IN CHILDREN

Outpatient use of antibiotics is common in paediatrics but certain antibiotics, especially those with a relatively broad spectrum, frequently result in diarrhoea. The mechanism by which antibiotic-associated diarrhoea occurs most likely relates to disturbances of microbial flora in the gastrointestinal tract. Disruption of the microbial flora may result in the overgrowth of pathogenic organisms such as Clostridium difficile or may disturb the metabolism of carbohydrates, resulting in malabsorption of osmotically active particles. Therefore, a study was carried out to determine the efficacy of Lactobacillus casei sps. Rhamnosus (Lactobacillus GG) (LGG) in reducing the incidence of antibiotic-associated diarrhoea when co-administered with an oral antibiotic. The study group consisted of 202 children between 6 months and 10 years of age. LGG or comparable placebo was administered in a double-blind randomised trial to children receiving oral antibiotics. It was found that 25 placebo-treated but only 7 LGG-treated patients had diarrhoea as defined by liquid stools numbering 2 or greater per day. Lactobacillus GG overall significantly reduced stool frequency and increased stool consistency during antibiotic therapy compared to placebo.
Vanderhoof, J.A. et al
J. PEDIATR. 1999, 135 (5) 564-8

Related Books
Practitoners Search
Health Centre Search
Sitemap  |  Disclaimer  |  Developed by moragan